3 Year Absolute Returns
71.60% ↑
NAV (₹) on 19 Oct 2026
34.83
1 Day NAV Change
-1.07%
Risk Level
Very High Risk
Rating
-
LIC MF Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by LIC Mutual Fund Asset Management Limited. Launched on 08 Feb 2019, investors can start with a minimum ... Read more
AUM
₹ 99.36 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 62.72% |
| Hospitals & Medical Services | 29.83% |
| Chemicals - Others | 4.98% |
| Treps/Reverse Repo | 2.57% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 9.59% | ₹ 9.53 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 9.07% | ₹ 9.01 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 6.14% | ₹ 6.10 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 6.04% | ₹ 6 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 5.75% | ₹ 5.72 | Hospitals & Medical Services |
| Aurobindo Pharma Ltd. | 5.23% | ₹ 5.19 | Pharmaceuticals |
| Navin Fluorine International Ltd. | 4.98% | ₹ 4.95 | Chemicals - Others |
| Zydus Lifesciences Ltd. | 4.97% | ₹ 4.94 | Pharmaceuticals |
| Aster DM Quality Care Ltd. | 4.61% | ₹ 4.58 | Hospitals & Medical Services |
| Fortis Healthcare Ltd. | 3.77% | ₹ 3.74 | Hospitals & Medical Services |
| Metropolis Healthcare Ltd. | 3.35% | ₹ 3.33 | Hospitals & Medical Services |
| Gland Pharma Ltd. | 3.20% | ₹ 3.18 | Pharmaceuticals |
| Mankind Pharma Ltd. | 3.11% | ₹ 3.09 | Pharmaceuticals |
| Nephrocare Health Services Ltd. | 3.05% | ₹ 3.03 | Hospitals & Medical Services |
| Max Healthcare Institute Ltd. | 2.99% | ₹ 2.98 | Hospitals & Medical Services |
| Cohance Lifesciences Ltd. | 2.95% | ₹ 2.93 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 2.61% | ₹ 2.59 | Pharmaceuticals |
| Global Health Ltd. | 2.59% | ₹ 2.58 | Hospitals & Medical Services |
| Treps | 2.57% | ₹ 2.55 | Others |
| Dr Agarwal's Health Care Ltd. | 2.46% | ₹ 2.44 | Hospitals & Medical Services |
| Biocon Ltd. | 2.37% | ₹ 2.35 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 2.33% | ₹ 2.31 | Pharmaceuticals |
| Onesource Specialty Pharma Ltd. | 2.30% | ₹ 2.28 | Pharmaceuticals |
| Piramal Pharma Ltd. | 1.43% | ₹ 1.43 | Pharmaceuticals |
| Syngene International Ltd. | 1.38% | ₹ 1.37 | Pharmaceuticals |
| Artemis Medicare Services Ltd. | 1.26% | ₹ 1.25 | Hospitals & Medical Services |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 11.34% | 5.85% | 3.55% | 19.72% |
| Category returns | 2.10% | 0.26% | 1.47% | 19.00% |
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 103.02% | 299.93% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 103.02% | 299.93% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 103.02% | 299.93% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.58 | 100.31% | 283.82% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.58 | 100.31% | 283.82% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.58 | 100.31% | 283.82% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.93 | 17.72% | 142.84% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.93 | 17.72% | 142.84% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.93 | 17.72% | 142.84% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹28.84 | 16.59% | 135.12% | 0.00% | ₹11,493 | 1.79% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
LIC MF Gold ETF
ETF
Regular
|
₹130.35 | 11.82% | 138.30% | 198.44% | ₹1,441 | 0.45% |
High
|
|
LIC MF Gold ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹39.48 | 9.19% | 135.71% | 195.29% | ₹833 | 0.35% |
High
|
|
LIC MF Gold ETF FOF
Fund of Funds
Regular
|
₹37.31 | 8.88% | 133.09% | 189.62% | ₹833 | 0.61% |
High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹60.15 | 4.78% | 74.72% | 150.93% | ₹1,153 | 1.33% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹59.05 | 4.78% | 74.62% | 149.89% | ₹1,153 | 1.33% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹59.05 | 4.78% | 74.62% | 149.89% | ₹1,153 | 1.33% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹34.82 | 5.84% | 71.55% | 71.08% | ₹99 | 1.37% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹34.82 | 5.84% | 71.55% | 71.08% | ₹99 | 1.37% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹51.73 | 3.38% | 67.93% | 135.81% | ₹1,153 | 2.67% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹51.74 | 3.38% | 67.92% | 135.80% | ₹1,153 | 2.67% |
Very High
|
What is the current NAV of LIC MF Healthcare Fund - Direct Plan Growth?
What is the fund size (AUM) of LIC MF Healthcare Fund - Direct Plan Growth?
What are the historical returns of LIC MF Healthcare Fund - Direct Plan Growth?
What is the risk level of LIC MF Healthcare Fund - Direct Plan Growth?
What is the minimum investment amount for LIC MF Healthcare Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article